摘要:
The present invention relates to a process of preparing commercial quantities of glucose and/or fructose from sucrose, a process of preparing commercial quantities of glucose and a polyfructan from sucrose, a reactor for practicing same, a process of preparing commercial quantities of fructose and a polyglucan from sucrose and a reactor for practicing same.
摘要:
The invention relates to methods for attenuating xenograft rejection in humans and old world monkeys, using oligosaccharides containing a Gal.alpha.1-3Gal motif, to neutralize or remove anti-.alpha.Gal antibodies. The invention additionally relates to methods for site directed activation of the complement cascade or host leukocytes using oligosaccharides containing a Gal.alpha.1-3Gal motif to target anti-.alpha.Gal antibodies. The invention further relates to pharmaceutical compositions that may be used in the practice of the invention. Such compositions contain, as the active ingredient, an oligosaccharide containing a Gal.alpha.1-3Gal motif effective in binding anti-.alpha.Gal antibodies in vivo or ex vivo.
摘要:
A method for treating and/or inhibiting gastric and duodenal ulcers, comprising administering a pharmaceutical composition comprising an oligosaccharide of Formula I(NeuAc-.alpha.(2-3)-pGal-.beta.(1)-(--X--).sub.m --(--Y--).sub.n -).sub.p -ZwhereinX=a chemical bond or a group capable of linking the p galactose to either the linking group Y or the multivalent support Z;wherein the C.sub.1 glycosidic oxygen of galactose may be replaced by N, S or C;Y=a linking group;Z=a multivalent support;m=0 or 1;n=0 or 1; andp=an integer of 2-1,000 is described. Also described is a method for treating and/or inhibiting gastric and duodenal ulcers, comprising administering a pharmaceutical composition comprising an oligosaccharide of Formula IINeuAc-.alpha.(2-3)-pGal-.beta.(1)-AwhereinA=a group capable of bonding to the p galactose;wherein the C.sub.1 glycosidic oxygen of galactose may be replaced by N, S or C.
摘要翻译:一种治疗和/或抑制胃十二指肠溃疡的方法,包括给予包含式I的寡糖的药物组合物(NeuAc-α(2-3)-pGal-β(1) - ( - X-)m - ( - Y-)n-)pZ其中X =化学键或能够将p半乳糖与连接基团Y或多价载体Z连接的基团; 其中半乳糖的C1糖苷氧可以被N,S或C代替; Y =连接基团; Z =多价支持; m = 0或1; n = 0或1; 并且描述p = 2-1,000的整数。 还描述了治疗和/或抑制胃十二指肠溃疡的方法,包括给予包含式II的寡糖NeuAc-α(2-3)-pGal-β(1)-A的药物组合物,其中A =能够 与p半乳糖结合; 其中半乳糖的C1糖苷氧可以被N,S或C替代。
摘要:
An artificial Christmas tree has a trunk. The trunk has a branch retaining rod and a plurality of branch retaining ports in the branch retaining rod. There is a branch retaining rod horizontal support member releasably attached to one end of the branch retaining rod. A branch retaining rod vertical support member is attached to another end of the branch retaining rod. There are a plurality of flexible branches. Each flexible branch has a flexible member and a plurality of artificial needles retained in the flexible member. The flexible member has an insertion end for insertion into a branch retaining port. There is an ornament retaining member releasably attached to the flexible branches. The ornament retaining member has a hinged retaining clip and a spring. The spring is attached to and biases the hinged retaining clip from an open position to an closed position. The branch retaining rod also has at least two interconnectable sections releasably and threadingly connected together or alternatively foldingly connected.
摘要:
The present invention relates to a process of preparing commercial quantities of glucose and/or fructose from sucrose, a process of preparing commercial quantities of glucose and a polyfructan from sucrose, a reactor for practicing same, a process of preparing commercial quantities of fructose and a polyglucan from sucrose and a reactor for practicing same.
摘要:
A method for treating and/or inhibiting gastric and duodenal ulcers, comprising administering a pharmaceutical composition comprising an oligosaccharide of Formula I (NeuAc-.alpha.(2-3)-pGal-.beta.(1)--(--X--).sub.m --(--Y--).sub.n --).sub.p --Z wherein X=a chemical bond or a group capable of linking the p galactose to either the linking group Y or the multivalent support Z; wherein the C.sub.1 glycosidic oxygen of galactose may be replaced by N, S or C; Y=a linking group; Z=a multivalent support; m=0 or 1; n=0 or 1; and p=an integer of 2-1,000 is described. Also described is a method for treating and/or inhibiting gastric and duodenal ulcers, comprising administering a pharmaceutical composition comprising an oligosaccharide of Formula II NeuAc-.alpha.(214 3)-pGal-.beta.(1)-A wherein A=a group capable of bonding to the p galactose; wherein the C.sub.1 glycosidic oxygen of galactose may be replaced by N, S or C.
摘要翻译:一种治疗和/或抑制胃十二指肠溃疡的方法,包括给予包含式I的寡糖的药物组合物(NeuAc-α(2-3)-pGal-β(1) - ( - X-)m - ( - Y-)n-)pZ其中X =化学键或能够将p半乳糖与连接基团Y或多价载体Z连接的基团; 其中半乳糖的C1糖苷氧可以被N,S或C代替; Y =连接基团; Z =多价支撑; m = 0或1; n = 0或1; 并且描述p = 2-1,000的整数。 还描述了治疗和/或抑制胃和十二指肠溃疡的方法,包括给予包含式II NeuAc-α(214 3)-pGal-β(1)-A的寡糖的药物组合物,其中A =能够 与p半乳糖结合; 其中半乳糖的C1糖苷氧可以被N,S或C替代。
摘要:
A method for treating and/or inhibiting gastric and duodenal ulcers, comprising administering a pharmaceutical composition comprising an oligosaccharide of Formula I(NeuAc-.alpha.(2-3)-Gal-.beta.(1)-(--X--).sub.m -(--Y--).sub.n -).sub.p -ZwhereinX=a chemical bond or a group capable of linking the galactose to either the linking group Y or the multivalent support Z;wherein the C.sub.1 glycosidic oxygen of galactose may be replaced by N, S or C;Y=a linking group;Z=a multivalent support;m=0 or 1;n=0 or 1; andp=an integer of 2-1,000 is described. Also described is a method for treating and/or inhibiting gastric and duodenal ulcers, comprising administering a pharmaceutical composition comprising an oligosaccharide of Formula IINeuAc-.alpha.(2-3)-Gal-.beta.(1)-AwhereinA=a group capable of bonding to the galactose;wherein the C.sub.1 glycosidic oxygen of galactose may be replaced by N, S or C.
摘要翻译:一种用于治疗和/或抑制胃和十二指肠溃疡的方法,包括给予包含式I的寡糖的药物组合物(NeuAc-α(2-3)-Gal-β(1) - ( - X-)m - ( - Y-)n-)pZ其中X =化学键或能够将半乳糖连接至连接基团Y或多价载体Z的基团; 其中半乳糖的C1糖苷氧可以被N,S或C代替; Y =连接基团; Z =多价支撑; m = 0或1; n = 0或1; 并且描述p = 2-1,000的整数。 还描述了治疗和/或抑制胃和十二指肠溃疡的方法,包括给予包含式II NeuAc-α(2-3)-Gal-β(1)-A的寡糖的药物组合物,其中A =能够 与半乳糖结合; 其中半乳糖的C1糖苷氧可以被N,S或C替代。
摘要:
The present invention relates to a process of preparing commercial quantities of glucose from sucrose, a process of preparing commercial quantities of glucose and a branched fructan from sucrose, a reactor for practicing same.
摘要:
The present invention relates to a process of preparing commercial quantities of glucose and/or fructose from sucrose, a process of preparing commercial quantities of glucose and a polyfructan from sucrose, a reactor for practicing same, a process of preparing commercial quantities of fructose and a polyglucan from sucrose and a reactor for practicing same.
摘要:
A composition for treating and/or inhibiting gastric and duodenal ulcers, comprising an oligosaccharide selected from the group consisting of Formula I ##STR1## or a mixture thereof; wherein:X is independently OH or NHAc;Y is independently H, or an amino acid or a peptide of 2-100, preferably 2-20, amino acids; andW, W', and W" are each independently H or ##STR2## where Z is independently H or a pharmaceutically acceptable cation; and P is independently H or ##STR3## where Z is defined as above; wherein at least one of W, W' or W" is an .alpha.-N-acetylneuraminic acid moiety, andwherein W' and W" are not simultaneously .alpha.-N-acetylneuraminic acid moietywith the proviso that the compound of Formula II is not NAN .alpha.(2.fwdarw.3)Gal .beta.1-4 Glu or NAN .alpha.(2.fwdarw.6)Gal .beta.1-4 Glu; and a kit for detecting the presence of Helicobacter pylori comprising at least one compound of the Formula I or II, are described.